CAS: 4642-95-9; (8S,13S,14S)-13-Methyl-1,2,6,7,8,14,15,16-Octahydrocyclopenta[a]Phenanthrene-3,17-Dione

该化合物是一种合成新陈代谢类固醇,产自激素睾酮,以其潜力促进肌肉生长,提高运动性能,在健体和运动员中受到欢迎.化学学上,Trendione的特点是其独特的结构,包括一个有助于其新陈特性的氯酮组,通常以允许口服的形式进行,其影响可包括增加蛋白合成,改进氮保留和锻炼后恢复.然而,像许多代谢类固醇一样,Trendione还可能带来副作用风险,包括荷尔蒙失衡,肝毒性和心血管问题.由于这些潜在的健康风险及其增强性能的影响,在竞争性体育中经常对其使用加以管制或禁止.与任何代谢剂一样,考虑使用该物质的个人应当意识到其消费所涉及的法律和健康影响.

结构式图片

上下游产品

群勃龙 Trenbolone 10161-33-8

合成工艺路线路线简述

  • 合成目标产物 Trendione 主要起始原料 Trenbolone
  • (文献来源)合成步骤主要原料 Trenbolone
📜群勃龙置于草酰氯,二甲基亚砜,三乙胺体系中,化学反应生成 三烯
参考文献:Synthesis And Sar Study Of Novel Pseudo-Steroids As Potent And Selective Progesterone Receptor Antagonists
标题:Synthesis And Sar Study Of Novel Pseudo-Steroids As Potent And Selective Progesterone Receptor Antagonists
摘要:Synthesis Of Novel 7-Pseudo-Steroids 1C Has Been Achieved From Trenbolone 3 Via An Efficient 14 Step Sequence With Overall Yields Of 10-15%. Various Substitutions Were Incorporated At Both The Aromatic Side Chain As Well As The D Ring. The Orientation Of Aromatic Side Chain At C10 Plays A Crucial Role For Progesterone Receptor (Pr) Activity. Compound 2A (T47D = 1 Nm) With-Nme2 Para To The Aromatic Group Along With Spirofurane Groups In The D Ring Was The Optimal Substitution. All Compounds Were Also Evaluated For Glucocorticoid Receptor (Gr) Antagonist Activities In Vivo In A Rat And Found Efficacious In Uterine Complement C3 Assay Via The Oral Route Of Administrations. (C) 2009 Elsevier Ltd. All Rights Reserved.
DOI:10.1016/j.Bmcl.2009.01.095

海关参考信息

专利信息


专利号:CN-119799661-A
优先权日:2023-10-09
标 题:Application of cytochrome P450BM3 mutant in allyl progestogen synthesis

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

主要参考文献


1: Robinson JA, Ma Q, Staveley JP, Smolenski WJ. Sorption and desorption of 17α-trenbolone and trendione on five soils. Environ Toxicol Chem. 2017 Mar;36(3):613-620. doi: 10.1002/etc.3711. 36(3):630-635. doi: 10.1002/etc.3381. Epub 2016 Jun 13. 42(10):3570-4. doi: 10.1021/es702690p. 79(8):873-9. doi: 10.1016/j.chemosphere.2010.02.036. Epub 2010 Mar 15. 85(3):1317-23. doi: 10.1016/j.talanta.2011.06.011. Epub 2011 Jun 14.
202:1-7. doi: 10.1016/j.ygcen.2014.04.011. Epub 2014 Apr 26.
85:110-4. doi: 10.1016/j.ecoenv.2012.08.006. Epub 2012 Sep 2. 43(23):8827-33. doi: 10.1021/es902112v. 55(3):1730-1739. doi: 10.1021/acs.est.0c06450. Epub 2021 Jan 15. 34(7):1472-84. doi: 10.1002/etc.2962. Epub 2015 May 14. 48(7):3715-23. doi: 10.1021/es405701f. Epub 2014 Mar 19.

合成参考文献


摘要:21 CFR Sections 1308.11-1308.15
摘要:S109 | PARCEDC | List of 7074 potential endocrine disrupting compounds (EDCs) by PARC T4.2 | DOI:10.5281/zenodo.10944198
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知